The Advisory Team at Cleave Therapeutics provides strategic guidance to enhance the company’s development and business initiatives. Comprised of experts in both development and business, the team advises on clinical strategy, market positioning, and partnership opportunities, ensuring that the company effectively advances its innovative therapies targeting VCP/p97 in cancer and neurodegenerative diseases.